BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34586745)

  • 1. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis.
    Liu W; Zhou Y; Duan W; Song J; Wei S; Xia S; Wang Y; Du X; Li E; Ren C; Wang W; Zhan Q; Wang Q
    Clin Transl Med; 2021 Sep; 11(9):e517. PubMed ID: 34586745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
    Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
    Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells.
    Ni J; Chen K; Zhang J; Zhang X
    Biochem Biophys Res Commun; 2021 Aug; 567():154-160. PubMed ID: 34157442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
    Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
    Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutathione peroxidase 4 restrains temporomandibular joint osteoarthritis progression by inhibiting ferroptosis.
    Pang C; Zhang H; Liu Y; Tang N; Tian K; Mu Y; Li X; Xiao L
    J Cell Mol Med; 2024 May; 28(9):e18377. PubMed ID: 38686488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma.
    Lai Y; Zhang Z; Li J; Li W; Huang Z; Zhang C; Li X; Zhao J
    Biochem Biophys Res Commun; 2019 Nov; 519(4):659-666. PubMed ID: 31542233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
    Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
    J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis.
    Han B; Liu Y; Zhang Q; Liang L
    J Proteomics; 2023 Mar; 274():104777. PubMed ID: 36427803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase zeta 1 alters the HMGB1/GPX4 axis to drive ferroptosis in bladder cancer cells.
    Zhu H; Chen Q; Zhang Y; Zhao L
    Hum Exp Toxicol; 2023; 42():9603271231161606. PubMed ID: 36905252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High co-expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer.
    Wu X; Shen S; Qin J; Fei W; Fan F; Gu J; Shen T; Zhang T; Cheng X
    BJOG; 2022 Nov; 129 Suppl 2(Suppl 2):40-49. PubMed ID: 36485069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidase 1 promotes ferroptosis in renal tubular epithelial cells in diabetic nephropathy via inhibition of the GSH/GPX4 axis.
    Li Y; Wang X; Zhang Q; Tian D; Bai Y; Feng Y; Liu W; Diao Z
    Int Immunopharmacol; 2024 May; 133():111955. PubMed ID: 38626544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4.
    Zhao G; Liang J; Shan G; Gu J; Xu F; Lu C; Ma T; Bi G; Zhan C; Ge D
    Commun Biol; 2023 May; 6(1):570. PubMed ID: 37248295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis.
    Zhao Y; Ren P; Yang Z; Wang L; Hu C
    Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36453257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model.
    Xu M; Wang Y; Duan W; Xia S; Wei S; Liu W; Wang Q
    Front Bioeng Biotechnol; 2020; 8():612091. PubMed ID: 33415100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
    Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
    Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
    EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro.
    Feng Q; Hao S; Fang P; Zhang P; Sheng X
    Mol Biol Rep; 2023 Dec; 50(12):10189-10198. PubMed ID: 37924448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma.
    Wang Z; Zhang X; Tian X; Yang Y; Ma L; Wang J; Yu Y
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.